Genetic Manipulation and Hybridization Update

Genetic Defilement: CRISPR Gene Editing Will Be Used Inside Humans For the First Time in Treatment for Blindness

‘As in the days of Noah.’ Genetic corruption and defilement of flesh.

Matthew 24:37 But as the days of Noah were, so shall also the coming of the Son of man be.

Genesis 6:9, 11, 12 These are the generations of Noah: Noah was a just man and perfect in his generations, and Noah walked with God. The earth also was corrupt before God, and the earth was filled with violence. And God looked upon the earth, and, behold, it was corrupt; for all flesh had corrupted his way upon the earth.

Genesis 7:1-4  And the Lord said unto Noah, Come thou and all thy house into the ark; for thee have I seen righteous before me in this generation. Of every clean beast thou shalt take to thee by sevens, the male and his female: and of beasts that are not clean by two, the male and his female. Of fowls also of the air by sevens, the male and the female; to keep seed alive upon the face of all the earth. For yet seven days, and I will cause it to rain upon the earth forty days and forty nights; and every living substance that I have made will I destroy from off the face of the earth.

Saudi Arabia – Mohammed bin Salman – NEOM; There will also be gene-editing facilities that will be used to make humans stronger and smarter than ever before, according to the Wall Street Journal.

Genetic Defilement: CRISPR Gene Editing Will Be Used Inside Humans For the First Time in Treatment for Blindness

By Rachael Rettner. July 30, 2019. Live Science.

The first study to test the gene-editing technology CRISPR inside the human body is about to get underway in the United States, according to news reports.

The study plans to use CRISPR to treat an inherited eye disorder that causes blindness, according to the Associated Press.

People with this condition have a mutation in a gene that affects the function of the retina, the light-sensitive cells at the back of the eye that are essential for normal vision. The condition is a form of Leber congenital amaurosis, one of the most common causes of childhood blindness that affects about 2 to 3 newborns out of every 100,000, according to the National Institutes of Health.

The treatment will correct the mutation using CRISPR, a tool that allows researchers to precisely edit DNA in a specific spot, the AP reported.

Researchers will use an injection to deliver the treatment directly to the light-sensitive cells, according to a statement from Editas Medicine, the company that is conducting the study along with Allergan.

The trial will enroll a total of 18 patients, both children (ages 3 and up) and adults.

The new study is different from the controversial research of a Chinese scientist who used CRISPR to edit the genomes of twin babies last year. In that case, the Chinese scientist edited the DNA of embryos, and these gene alterations could be passed down to the next generation, the AP reported. In the new study, the DNA edits made in the children and adults cannot be passed down to their offspring, the AP said.

Leave a Reply